AI 聊天
正在加载 ELAB 的数据(首次访问,需要几秒钟)。

PMGC Holdings Inc.

ELAB · NasdaqCM · USD

2.77 -0.27 (-8.88%)

收盘价: Oct 16, 2026, 4:00 PM EDT

市值
$2.24M
成交量
12.6K

PMGC Holdings Inc.(ELAB)股价、分析与数据

时间间隔:1D
正在加载K线和信号…

内在价值

估值模型属于 Pro 功能。登录或升级后可查看完整分析。

查看方案 →

分析师预测

股票预测 →

分析师预测不可用

12个月目标价 · n/a 位分析师

分析师一致意见: n/a

您正在查看免费概览

创建免费账户,探索更多关于此标的的研究资料。

财务表现

查看财务 →

加载中...

最新财报

已公布较预期同比变动
营收—n/an/a
每股收益(TTM)—n/an/a

下次财报

查看财报详情 →

指标

买价
2.27
市值
2.24M
净利润(TTM)
-13.6M
-0.27
-1748.36
n/a
n/a
市净率(TTM)
0.10
市销率(TTM)
0.87
财报日期
n/a
卖价
3.32
成交量
12,550
20日均量
53,010
开盘价
3.00
前收盘价
3.04
日内区间
2.68 - 3.03
52周区间
2.58 - 1771.20
分红
n/a
除息日
n/a

关于 PMGC Holdings Inc.

查看公司资料 →
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California. Biotechnology · Healthcare

PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

板块 Healthcare
上市日期 Nov 21, 2023
员工人数 32
交易所 NasdaqCM
股票代码 ELAB